Label & Claims

OTC Drug Facts Label & Claims Compliance Review

Detailed review of OTC packaging labels against US FDA 21 CFR 201, aligning Drug Facts panels, active ingredient claims, and preventing unapproved drug claims.

Statutory Formatting for Drug Facts Labeling

OTC labels are heavily targeted by U.S. FDA customs enforcement and class-action lawsuits. The outer packaging must present the standardized "Drug Facts" panel. We correct font sizes, line heights, sections, and evaluate claim risks.

  • Principal Display Panel (PDP): active ingredients, primary use, and net contents formatting
  • Drug Facts Panel: verifying font size (min 6pt), line thickness, and layout
  • Indications & Warnings: ensuring text aligns with FDA-established monographs